Biogen Inc. buy Vassago1
Start price
27.07.15
/
50%
€275.42
Target price
27.01.16
€306.69
Performance (%)
-14.89%
End price
27.01.16
€234.40
Summary
This prediction ended on 27.01.16 with a price of €234.40. The prediction for Biogen Inc. disappointed with a performance of -14.89%. Vassago1 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biogen Inc. | -5.540% | -5.540% | -19.874% | -28.538% |
iShares Core DAX® | 0.786% | 1.251% | 11.561% | 16.636% |
iShares Nasdaq 100 | 1.855% | -2.687% | 25.316% | 43.346% |
iShares Nikkei 225® | 3.947% | 2.199% | 11.527% | 12.586% |
iShares S&P 500 | 1.787% | 0.151% | 23.699% | 42.958% |
Comments by Vassago1 for this prediction
In the thread Biogen Inc. diskutieren
NPM 36%
kurze Q3 Info:
Biogen hat Analystenerwartungen beim Umsatz u. Gewinn klar übertroffen. Die EPS Prognose wurde für das lfd. Jahr angehoben und neue Rekordumsätze bei Tecfidera, Plegridy, Alprolix, und Eloctate erzielt. NPM 35%.
http://media.biogen.com/press-release/investor-relations/biogen-third-quarter-2015-revenues-increase-11-28-billion-company-r
(Laufzeit überschritten)